ZYBTZhengye Biotechnology Holding Ltd$1.50Nov 13 close-0.7%1M-2.0%6M+57.9%1Y-31.8%

Overview Financials Earnings Peers Projection Compare

Loading company

Every figure taken straight from a company’s own SEC filings, with the checks behind each grade shown — and whatever could not be found named rather than hidden.

Appearance

Product

Screener
Earnings calendar
Watchlists
Portfolios

Browse

Rankings
Free this week
Industries
Curated lists
Fund managers

Company

About
How the grade works
Glossary
Pricing
Contact

Legal

Terms of service
Privacy policy
Disclaimer
Cookie policy

InspectStocks describes businesses using their own reported figures. It is not investment advice and does not recommend buying or selling anything.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Zhengye Biotechnology Holding Ltd (ZYBT) latest earnings — what was reported — InspectStocks

ZYBTZhengye Biotechnology Holding Ltd$1.50Nov 13 close-0.7%1M-2.0%6M+57.9%1Y-31.8%

Compare

Overview Financials Earnings Peers Projection Compare

Zhengye Biotechnology Holding Ltd

ZYBT · Nasdaq · Healthcare · Drug Manufacturers Specialty and Generic

Grade DMixed

Compare

$1.50-0.7%Nov 13 close

Figures through December 31, 2025, from the 20-F filed April 28, 2026

Past performance

1W: 0.0%
1M: -2.0%
3M: -3.8%
6M: +57.9%
1Y: -31.8%

The latest quarter we hold for Zhengye Biotechnology Holding Ltd

From the company’s own 6-K filing.

Earnings calls

Zhengye Biotechnology Holding Ltd has no earnings call transcript available.

The quote and the company description come from the 6-K Zhengye Biotechnology Holding Ltd filed on December 12, 2025 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.